Bixiye
Skyclarys™ (omaveloxolone) - Commercial
Prior Authorization, Quantity Limit
Taariikhda barnaamijka Dhaqangalayso Agosto 01, 2024
Natiijooyinka Raadinta
Soo bandhiga 1341 - 1350 ee natiijooyinka 3685
Bixiye
Ophthalmic Pilocarpine - Commercial
Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2025
Bixiye
Ophthalmic Prostaglandins - Commercial
Quantity Limit
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 01, 2024
Bixiye
Daybue™ (trofinetide) - Commercial
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2025
Bixiye
Antiretroviral - Commercial
Quantity Limit
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 01, 2024
Bixiye
Benign Prostatic Hypertrophy (BPH) - Commercial
Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: Jan 01, 2025
Bixiye
Ophthalmic Prostaglandins - Medicaid
Quantity Limit
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 01, 2024
Bixiye
Angiotensin II Receptor Antagonists (ARBs), Renin Inhibitors and Combinations - Medicaid
Quantity Limit
Taariikhda uu dhaqangalayo barnaamijka: Okt 01, 2024
Bixiye
Daybue™ (trofinetide) - Medicaid
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2025
Bixiye
Antiretroviral - Medicaid
Quantity Limit
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 01, 2024